64 related articles for article (PubMed ID: 14560965)
1. mTOR as a positive regulator of tumor cell responses to hypoxia.
Abraham RT
Curr Top Microbiol Immunol; 2004; 279():299-319. PubMed ID: 14560965
[TBL] [Abstract][Full Text] [Related]
2. GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer.
Scott KL; Kabbarah O; Liang MC; Ivanova E; Anagnostou V; Wu J; Dhakal S; Wu M; Chen S; Feinberg T; Huang J; Saci A; Widlund HR; Fisher DE; Xiao Y; Rimm DL; Protopopov A; Wong KK; Chin L
Nature; 2009 Jun; 459(7250):1085-90. PubMed ID: 19553991
[TBL] [Abstract][Full Text] [Related]
3. Duality of the SVIL expression in bladder cancer and its correlation with immune infiltration.
Nie Z; Guo N; Peng Y; Gao Y; Cao H; Zhang S
Sci Rep; 2023 Sep; 13(1):14595. PubMed ID: 37670039
[TBL] [Abstract][Full Text] [Related]
4. Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee.
Thompson PA; Malogolowkin MH; Furman WL; Piao J; Krailo MD; Chung N; Brock L; Towbin AJ; McCarville EB; Finegold MJ; Ranganathan S; Dunn SP; Langham MR; McGahren ED; Tiao GM; Weldon CB; O'Neill AF; Rodriguez-Galindo C; Meyers RL; Katzenstein HM
Pediatr Blood Cancer; 2023 Jul; 70(7):e30365. PubMed ID: 37073741
[TBL] [Abstract][Full Text] [Related]
5. Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches.
Carvalho TMA; Di Molfetta D; Greco MR; Koltai T; Alfarouk KO; Reshkin SJ; Cardone RA
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885243
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells?
Mollaei M; Hassan ZM; Khorshidi F; Langroudi L
Transl Oncol; 2021 May; 14(5):101056. PubMed ID: 33684837
[TBL] [Abstract][Full Text] [Related]
7. Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials.
Harsha C; Banik K; Ang HL; Girisa S; Vikkurthi R; Parama D; Rana V; Shabnam B; Khatoon E; Kumar AP; Kunnumakkara AB
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32384682
[TBL] [Abstract][Full Text] [Related]
8. Nutrient and Stress Sensing in Pathogenic Yeasts.
Rutherford JC; Bahn YS; van den Berg B; Heitman J; Xue C
Front Microbiol; 2019; 10():442. PubMed ID: 30930866
[TBL] [Abstract][Full Text] [Related]
9. Reactive Oxygen Species Signaling Promotes Hypoxia-Inducible Factor 1α Stabilization in Sonic Hedgehog-Driven Cerebellar Progenitor Cell Proliferation.
Eyrich NW; Potts CR; Robinson MH; Maximov V; Kenney AM
Mol Cell Biol; 2019 Apr; 39(8):. PubMed ID: 30692272
[TBL] [Abstract][Full Text] [Related]
10. Recent Discoveries on the Role of TOR (Target of Rapamycin) Signaling in Translation in Plants.
Schepetilnikov M; Ryabova LA
Plant Physiol; 2018 Feb; 176(2):1095-1105. PubMed ID: 29122989
[TBL] [Abstract][Full Text] [Related]
11. Paeonol enhances the sensitivity of human ovarian cancer cells to radiotherapy-induced apoptosis due to downregulation of the phosphatidylinositol-3-kinase/Akt/phosphatase and tensin homolog pathway and inhibition of vascular endothelial growth factor.
Zhou HM; Sun QX; Cheng Y
Exp Ther Med; 2017 Oct; 14(4):3213-3220. PubMed ID: 28912871
[TBL] [Abstract][Full Text] [Related]
12. Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways.
Wee P; Wang Z
Cancers (Basel); 2017 May; 9(5):. PubMed ID: 28513565
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia Regulates mTORC1-Mediated Keratinocyte Motility and Migration via the AMPK Pathway.
Yan T; Zhang J; Tang D; Zhang X; Jiang X; Zhao L; Zhang Q; Zhang D; Huang Y
PLoS One; 2017; 12(1):e0169155. PubMed ID: 28068384
[TBL] [Abstract][Full Text] [Related]
14. Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer.
Coothankandaswamy V; Cao S; Xu Y; Prasad PD; Singh PK; Reynolds CP; Yang S; Ogura J; Ganapathy V; Bhutia YD
Br J Pharmacol; 2016 Dec; 173(23):3292-3306. PubMed ID: 27747870
[TBL] [Abstract][Full Text] [Related]
15. Influence of mTOR-inhibitors and mycophenolic acid on human cholangiocellular carcinoma and cancer associated fibroblasts.
Heits N; Heinze T; Bernsmeier A; Kerber J; Hauser C; Becker T; Kalthoff H; Egberts JH; Braun F
BMC Cancer; 2016 May; 16():322. PubMed ID: 27206490
[TBL] [Abstract][Full Text] [Related]
16. The Warburg effect and drug resistance.
Bhattacharya B; Mohd Omar MF; Soong R
Br J Pharmacol; 2016 Mar; 173(6):970-9. PubMed ID: 26750865
[TBL] [Abstract][Full Text] [Related]
17. A review of therapies for diabetic macular oedema and rationale for combination therapy.
Amoaku WM; Saker S; Stewart EA
Eye (Lond); 2015 Sep; 29(9):1115-30. PubMed ID: 26113500
[TBL] [Abstract][Full Text] [Related]
18. A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K.
Ma DJ; Galanis E; Anderson SK; Schiff D; Kaufmann TJ; Peller PJ; Giannini C; Brown PD; Uhm JH; McGraw S; Jaeckle KA; Flynn PJ; Ligon KL; Buckner JC; Sarkaria JN
Neuro Oncol; 2015 Sep; 17(9):1261-9. PubMed ID: 25526733
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia promotes uveal melanoma invasion through enhanced Notch and MAPK activation.
Asnaghi L; Lin MH; Lim KS; Lim KJ; Tripathy A; Wendeborn M; Merbs SL; Handa JT; Sodhi A; Bar EE; Eberhart CG
PLoS One; 2014; 9(8):e105372. PubMed ID: 25166211
[TBL] [Abstract][Full Text] [Related]
20. Targeting PI3K/Akt/mTOR Signaling in Cancer.
Porta C; Paglino C; Mosca A
Front Oncol; 2014; 4():64. PubMed ID: 24782981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
